일렉트로메드 (ELMD) 주가

일렉트로메드(ELMD)는 NYSE MKT에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $26.61 (+0.99%), 시가총액 $0.32B, PER (주가수익비율) 32.15, 52주 최저~최고 $18.12 ~ $38.58.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose

핵심 지표

• 현재가: $26.61 (+0.99%)
• 시가총액: $0.32B
• PER (주가수익비율): 32.15
• 52주 최저~최고: $18.12 ~ $38.58
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NYSE MKT

일렉트로메드의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

일렉트로메드 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 6.36
• 순이익률: 0.14%
• 영업이익률: 0.20%

자주 묻는 질문